Fully integrated Monte Carlo simulation for evaluating radiation induced DNA damage and subsequent repair using Geant4-DNA.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
27 11 2020
Historique:
received: 16 04 2020
accepted: 15 10 2020
entrez: 28 11 2020
pubmed: 29 11 2020
medline: 23 3 2021
Statut: epublish

Résumé

Ionising radiation induced DNA damage and subsequent biological responses to it depend on the radiation's track-structure and its energy loss distribution pattern. To investigate the underlying biological mechanisms involved in such complex system, there is need of predicting biological response by integrated Monte Carlo (MC) simulations across physics, chemistry and biology. Hence, in this work, we have developed an application using the open source Geant4-DNA toolkit to propose a realistic "fully integrated" MC simulation to calculate both early DNA damage and subsequent biological responses with time. We had previously developed an application allowing simulations of radiation induced early DNA damage on a naked cell nucleus model. In the new version presented in this work, we have developed three additional important features: (1) modeling of a realistic cell geometry, (2) inclusion of a biological repair model, (3) refinement of DNA damage parameters for direct damage and indirect damage scoring. The simulation results are validated with experimental data in terms of Single Strand Break (SSB) yields for plasmid and Double Strand Break (DSB) yields for plasmid/human cell. In addition, the yields of indirect DSBs are compatible with the experimental scavengeable damage fraction. The simulation application also demonstrates agreement with experimental data of [Formula: see text]-H2AX yields for gamma ray irradiation. Using this application, it is now possible to predict biological response along time through track-structure MC simulations.

Identifiants

pubmed: 33247225
doi: 10.1038/s41598-020-75982-x
pii: 10.1038/s41598-020-75982-x
pmc: PMC7695857
doi:

Substances chimiques

H2AX protein, human 0
Histones 0
DNA 9007-49-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20788

Références

FEBS Lett. 2010 Sep 10;584(17):3675-81
pubmed: 20580718
Radiat Res. 2007 Sep;168(3):367-81
pubmed: 17705640
Sci Rep. 2017 Mar 27;7:45161
pubmed: 28345622
Med Phys. 2018 Jun 14;:
pubmed: 29901835
Adv Space Res. 2001;27(2):393-9
pubmed: 11642301
Radiat Res. 2008 Feb;169(2):214-22
pubmed: 18220463
Phys Med. 2019 Jun;62:152-157
pubmed: 31109825
Rep Prog Phys. 2016 Nov;79(11):116601
pubmed: 27652826
Proc Natl Acad Sci U S A. 1955 Jul 15;41(7):432-7
pubmed: 16589695
Med Phys. 2015 Jul;42(7):3870-6
pubmed: 26133588
Int J Radiat Biol. 2005 Nov;81(11):841-54
pubmed: 16484153
Int J Radiat Biol. 1997 May;71(5):467-83
pubmed: 9191891
Curr Biol. 2003 Oct 28;13(21):R825-8
pubmed: 14588256
Int J Radiat Biol. 1994 Jan;65(1):7-17
pubmed: 7905912
Mutat Res. 2011 Jun 3;711(1-2):28-40
pubmed: 21281649
Int J Radiat Biol. 1998 Apr;73(4):355-64
pubmed: 9587072
Radiat Res. 2012 Oct;178(4):341-56
pubmed: 22880622
Curr Biol. 2000 Jul 27-Aug 10;10(15):886-95
pubmed: 10959836
Acta Oncol. 2011 Aug;50(6):757-62
pubmed: 21767171
Int J Radiat Biol. 2012 Dec;88(12):899-907
pubmed: 22668077
Radiat Res. 2009 Feb;171(2):212-8
pubmed: 19267547
J Biol Chem. 2003 Dec 5;278(49):49636-43
pubmed: 14507919
J Theor Biol. 2015 Feb 7;366:115-30
pubmed: 25261728
Int J Radiat Biol. 2000 Aug;76(8):1095-104
pubmed: 10947122
Phys Med. 2015 Dec;31(8):861-874
pubmed: 26653251
Indian J Physiol Pharmacol. 1998 Oct;42(4):440-52
pubmed: 10874342
Int J Radiat Biol. 1991 Feb;59(2):343-57
pubmed: 1671686
Int J Radiat Biol. 2000 Apr;76(4):539-47
pubmed: 10815635
Phys Med. 2018 Apr;48:146-155
pubmed: 29371062
Int J Mol Sci. 2019 Dec 09;20(24):
pubmed: 31835321
Int J Radiat Biol. 2019 Mar;95(3):274-285
pubmed: 30451568
Sci Rep. 2017 Sep 20;7(1):11923
pubmed: 28931851
J Exp Med. 1956 May 1;103(5):653-66
pubmed: 13319584
Radiat Res. 2001 Nov;156(5 Pt 2):577-83
pubmed: 11604075
Phys Med. 2016 Dec;32(12):1833-1840
pubmed: 27773539
Med Phys. 2019 Mar;46(3):1501-1511
pubmed: 30689203
Med Phys. 2010 Sep;37(9):4692-708
pubmed: 20964188
Radiat Res. 1998 Aug;150(2):170-82
pubmed: 9692362
Radiat Prot Dosimetry. 2019 May 1;183(1-2):121-125
pubmed: 30520984
Biophys J. 2002 Feb;82(2):944-62
pubmed: 11806935
PLoS Comput Biol. 2018 May 29;14(5):e1006159
pubmed: 29813054
Free Radic Res. 2016 Nov;50(sup1):S64-S78
pubmed: 27593437
Phys Med. 2018 Apr;48:135-145
pubmed: 29628360
Phys Med Biol. 2020 Apr 23;65(8):085015
pubmed: 32101803
Radiat Res. 1991 Dec;128(3):282-92
pubmed: 1961925
Phys Med Biol. 2018 Sep 06;63(17):175018
pubmed: 30088810
Radiat Res. 2003 Mar;159(3):401-10
pubmed: 12600243
Radiat Res. 2001 Oct;156(4):365-78
pubmed: 11554848
Radiat Res. 2008 Apr;169(4):437-46
pubmed: 18363429
Leukemia. 2010 Apr;24(4):679-86
pubmed: 20130602
Phys Med. 2018 Jul;51:108-116
pubmed: 29908994
Sci Rep. 2019 Sep 30;9(1):14019
pubmed: 31570741
J Cell Biol. 1999 Sep 6;146(5):905-16
pubmed: 10477747
J Biol Chem. 1998 Mar 6;273(10):5858-68
pubmed: 9488723
Int J Radiat Biol. 2005 Jan;81(1):41-54
pubmed: 15962762
Radiat Res. 1999 May;151(5):540-9
pubmed: 10319727
J Phys Chem Lett. 2013 Feb 19;4(5):820-825
pubmed: 24976899
Radiat Res. 2006 Jun;165(6):703-12
pubmed: 16802871

Auteurs

Dousatsu Sakata (D)

Department of Accelerator and Medical Physics, National Institute of Radiological Sciences, QST, Chiba, Japan. sakata.dousatsu@qst.go.jp.

Oleg Belov (O)

Joint Institute for Nuclear Research, Dubna, Russia.
Dubna State University, Dubna, Russia.

Marie-Claude Bordage (MC)

INSERM, UMR 1037, CRCT, Université Paul Sabatier, Toulouse, France.
UMR 1037, CRCT, Université Toulouse III-Paul Sabatier, Toulouse, France.

Dimitris Emfietzoglou (D)

Medical Physics Laboratory, Medical School, University of Ioannina, 45110, Ioannina, Greece.

Susanna Guatelli (S)

Centre For Medical Radiation Physics, University of Wollongong, Wollongong, Australia.

Taku Inaniwa (T)

Department of Accelerator and Medical Physics, National Institute of Radiological Sciences, QST, Chiba, Japan.

Vladimir Ivanchenko (V)

Geant4 Associates International Ltd, Hebden Bridge, UK.
Tomsk State University, Tomsk, Russia.

Mathieu Karamitros (M)

Unaffiliated, Bordeaux, France.

Ioanna Kyriakou (I)

Medical Physics Laboratory, Medical School, University of Ioannina, 45110, Ioannina, Greece.

Nathanael Lampe (N)

Unaffiliated, Melbourne, Australia.

Ivan Petrovic (I)

Vinca Institute of Nuclear Science, University of Belgrade, Belgrade, Serbia.

Aleksandra Ristic-Fira (A)

Vinca Institute of Nuclear Science, University of Belgrade, Belgrade, Serbia.

Wook-Geun Shin (WG)

Univ. Bordeaux, CNRS, CENBG, UMR 5797, Gradignan, 33170, France.

Sebastien Incerti (S)

Univ. Bordeaux, CNRS, CENBG, UMR 5797, Gradignan, 33170, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH